Next Issue
Previous Issue

Table of Contents

Pharmaceuticals, Volume 3, Issue 3 (March 2010), Pages 441-781

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Readerexternal link to open them.
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-17

Research

Jump to: Review

p. 441-447
by  and
Pharmaceuticals 2010, 3(3), 441-447; doi:10.3390/ph3030441
Received: 18 December 2009; in revised form: 12 February 2010 / Accepted: 2 March 2010 / Published: 2 March 2010
Show/Hide Abstract | PDF Full-text (524 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antihypertensive Drugs)
p. 621-635
by , , ,  and
Pharmaceuticals 2010, 3(3), 621-635; doi:10.3390/ph3030621
Received: 28 December 2009; in revised form: 5 March 2010 / Accepted: 9 March 2010 / Published: 12 March 2010
Show/Hide Abstract | PDF Full-text (431 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Cell-penetrating Peptides)
p. 679-701
by , , , ,  and
Pharmaceuticals 2010, 3(3), 679-701; doi:10.3390/ph3030679
Received: 18 December 2009; in revised form: 8 March 2010 / Accepted: 10 March 2010 / Published: 15 March 2010
Show/Hide Abstract | Cited by 2 | PDF Full-text (484 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antibiotics)
abstract graphic

Review

Jump to: Research

p. 448-470
by  and
Pharmaceuticals 2010, 3(3), 448-470; doi:10.3390/ph3030448
Received: 24 December 2009; in revised form: 6 February 2010 / Accepted: 1 March 2010 / Published: 2 March 2010
Show/Hide Abstract | Cited by 7 | PDF Full-text (525 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Cell-penetrating Peptides)
p. 471-481
by  and
Pharmaceuticals 2010, 3(3), 471-481; doi:10.3390/ph3030471
Received: 8 December 2009; in revised form: 11 February 2010 / Accepted: 3 March 2010 / Published: 5 March 2010
Show/Hide Abstract | Cited by 9 | PDF Full-text (203 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Generic Drugs)
p. 482-513
by
Pharmaceuticals 2010, 3(3), 482-513; doi:10.3390/ph3030482
Received: 12 January 2010; in revised form: 29 January 2010 / Accepted: 2 March 2010 / Published: 8 March 2010
Show/Hide Abstract | Cited by 2 | PDF Full-text (219 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Angiogenesis Inhibitors)
p. 514-540
by
Pharmaceuticals 2010, 3(3), 514-540; doi:10.3390/ph3030514
Received: 29 January 2010; Accepted: 2 March 2010 / Published: 8 March 2010
Show/Hide Abstract | Cited by 5 | PDF Full-text (1438 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antiasthmatic Drugs)
p. 541-557
by  and
Pharmaceuticals 2010, 3(3), 541-557; doi:10.3390/ph3030541
Received: 9 January 2010; in revised form: 7 February 2010 / Accepted: 5 March 2010 / Published: 8 March 2010
Show/Hide Abstract | PDF Full-text (2256 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Biomarkers)
p. 558-571
by ,  and
Pharmaceuticals 2010, 3(3), 558-571; doi:10.3390/ph3030558
Received: 2 January 2010; in revised form: 11 February 2010 / Accepted: 9 March 2010 / Published: 10 March 2010
Show/Hide Abstract | Cited by 3 | PDF Full-text (200 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Non-Steroidal Anti-Inflammatory Drugs)
p. 572-599
by  and
Pharmaceuticals 2010, 3(3), 572-599; doi:10.3390/ph3030572
Received: 28 January 2010; in revised form: 16 February 2010 / Accepted: 9 March 2010 / Published: 11 March 2010
Show/Hide Abstract | Cited by 9 | PDF Full-text (2001 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Angiogenesis Inhibitors)
p. 600-620
by  and
Pharmaceuticals 2010, 3(3), 600-620; doi:10.3390/ph3030600
Received: 26 December 2009; in revised form: 2 February 2010 / Accepted: 10 March 2010 / Published: 11 March 2010
Show/Hide Abstract | Cited by 8 | PDF Full-text (444 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Cell-penetrating Peptides)
p. 636-666
by  and
Pharmaceuticals 2010, 3(3), 636-666; doi:10.3390/ph3030636
Received: 18 December 2010; in revised form: 10 February 2010 / Accepted: 9 March 2010 / Published: 12 March 2010
Show/Hide Abstract | Cited by 9 | PDF Full-text (398 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Cell-penetrating Peptides)
abstract graphic
p. 667-678
by
Pharmaceuticals 2010, 3(3), 667-678; doi:10.3390/ph3030667
Received: 5 February 2010; in revised form: 3 March 2010 / Accepted: 8 March 2010 / Published: 15 March 2010
Show/Hide Abstract | PDF Full-text (95 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Targeted Therapy)
p. 702-724
by  and
Pharmaceuticals 2010, 3(3), 702-724; doi:10.3390/ph3030702
Received: 24 January 2010; in revised form: 24 February 2010 / Accepted: 5 March 2010 / Published: 16 March 2010
Show/Hide Abstract | Cited by 19 | PDF Full-text (161 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antidepressants)
p. 725-747
Review: Theophylline
by
Pharmaceuticals 2010, 3(3), 725-747; doi:10.3390/ph3030725
Received: 14 January 2010; Accepted: 18 March 2010 / Published: 18 March 2010
Show/Hide Abstract | Cited by 3 | PDF Full-text (363 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antiasthmatic Drugs)
p. 748-763
by
Pharmaceuticals 2010, 3(3), 748-763; doi:10.3390/ph3030748
Received: 9 December 2009; in revised form: 10 March 2010 / Accepted: 19 March 2010 / Published: 22 March 2010
Show/Hide Abstract | Cited by 5 | PDF Full-text (191 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Phytochemicals with actions on the Central Nervous System)
p. 764-781
by
Pharmaceuticals 2010, 3(3), 764-781; doi:10.3390/ph3030764
Received: 15 January 2010; in revised form: 3 March 2010 / Accepted: 19 March 2010 / Published: 22 March 2010
Show/Hide Abstract | Cited by 6 | PDF Full-text (1095 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antidiabetic Drugs)
Select/unselect all
Displaying article 1-17
Select articles Export citation of selected articles as:
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert